Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
S Chen, Q Cao, W Wen, H Wang - Cancer letters, 2019 - Elsevier
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, which
ranks as the sixth of cancer-related death. Despite the emergence of targeted therapy …
ranks as the sixth of cancer-related death. Despite the emergence of targeted therapy …
[引用][C] Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
S Chen, Q Cao, W Wen, H Wang - Cancer Letters, 2019 - cir.nii.ac.jp
Targeted therapy for hepatocellular carcinoma: Challenges and opportunities | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
S Chen, Q Cao, W Wen, H Wang - Cancer letters, 2019 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, which
ranks as the sixth of cancer-related death. Despite the emergence of targeted therapy …
ranks as the sixth of cancer-related death. Despite the emergence of targeted therapy …
Targeted therapy for hepatocellular carcinoma: Challenges and opportunities.
S Chen, Q Cao, W Wen, H Wang - Cancer Letters, 2019 - europepmc.org
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, which
ranks as the sixth of cancer-related death. Despite the emergence of targeted therapy …
ranks as the sixth of cancer-related death. Despite the emergence of targeted therapy …